Bahl & Gaynor Inc Pfizer Inc Transaction History
Bahl & Gaynor Inc
- $19.6 Billion
- Q1 2025
A detailed history of Bahl & Gaynor Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 42,170 shares of PFE stock, worth $984,669. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,170
Previous 47,982
12.11%
Holding current value
$984,669
Previous $1.27 Million
16.04%
% of portfolio
0.01%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding PFE
# of Institutions
3,369Shares Held
3.61BCall Options Held
102MPut Options Held
130M-
Vanguard Group Inc Valley Forge, PA523MShares$12.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$9.91 Billion0.27% of portfolio
-
State Street Corp Boston, MA297MShares$6.93 Billion0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA126MShares$2.93 Billion0.26% of portfolio
-
Wellington Management Group LLP Boston, MA103MShares$2.42 Billion0.52% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $131B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...